Работы, на которые ссылается эта работа
Работ: 154
Работа: A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance
Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications
Nida Iqbal, Nida Iqbal, Naveed Iqbal +1
Обзорная статья2014Цитирований: 6ABIComprehensive review of targeted therapy for colorectal cancer
Yuanhong Xie, Yingxuan Chen, Jing‐Yuan Fang
Обзорная статья2020Цитирований: 5ABIDiagnosis and Treatment of Metastatic Colorectal Cancer
Leah H. Biller, Deborah Schrag
Обзорная статья2021Цитирований: 4ABIAKT/PKB Signaling: Navigating the Network
Brendan D. Manning, Alex Toker
Обзорная статья2017Цитирований: 3ABIEmerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies
Nannan Wang, Yuepeng Cao, Chengshuai Si +5
Обзорная статья2022Цитирований: 3ABIImmune Checkpoint Inhibitors in Cancer Therapy
Yavar Shiravand, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani +6
Обзорная статья2022Цитирований: 3ABICharacteristics of the cancer stem cell niche and therapeutic strategies
Feng Ju, Manar Atyah, Nellie Horstmann +6
Обзорная статья2022Цитирований: 3ABISmall Molecule EGFR Inhibitors as Anti-Cancer Agents: Discovery, Mechanisms of Action, and Opportunities
Tanzida Zubair, Debasish Bandyopadhyay
Обзорная статья2023Цитирований: 3ABIAutophagy, cancer stem cells and drug resistance
Alexandra G. Smith, Kay F. Macleod
Обзорная статья2018Цитирований: 2ABIVEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
Yueshui Zhao, Sipeng Guo, Jian Min Deng +13
Обзорная статья2022Цитирований: 2ABIThe role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer
Jennifer L. Hsu, Mien‐Chie Hung
Обзорная статья2016Цитирований: 2ABINew findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?
Giuseppe Bronte, Nicola Silvestris, Marta Castiglia +10
Обзорная статья2015Цитирований: 2ABIVascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Обзорная статья2010Цитирований: 2ABIPharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years
Обзорная статья2014Цитирований: 2ABIThe emerging clinical relevance of genomics in cancer medicine
Michael F. Berger, Elaine R. Mardis
Обзорная статья2018Цитирований: 2ABINTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon
Обзорная статья2018Цитирований: 2ABIExpression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
Olivier Gires, Min Pan, Henrik Schinke +2
Обзорная статья2020Цитирований: 2ABIGrowth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
Constantin Ștefani, Daniela Miricescu, Iulia-Ioana Stănescu-Spînu +4
Обзорная статья2021Цитирований: 2ABIImpact of<scp>DNA</scp>damage response defects in cancer cells on response to immunotherapy and radiotherapy
Daniel Czajkowski, Radosław Szmyd, Harriet E. Gee
Обзорная статья2022Цитирований: 2ABIDNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities
Dana Jurkovičová, Christiana M. Neophytou, Ana Čipak Gašparović +1
Обзорная статья2022Цитирований: 2ABIResistance to targeted therapy in metastatic colorectal cancer: Current status and new developments
Yuanling Tang, Dandan Li, Jiayu Duan +2
Обзорная статья2023Цитирований: 2ABI